Literature DB >> 2026359

Microscopic ovarian metastasis of the uterine cervical cancer.

N Toki1, N Tsukamoto, T Kaku, N Toh, T Saito, T Kamura, K Matsukuma, H Nakano.   

Abstract

Six hundred forty-seven cases of carcinoma of the uterine cervix with FIGO stages Ib or more were initially treated with hysterectomy at Kyushu University Hospital from 1973 to 1987. In these, 597 cases could be pathologically reviewed for ovarian metastasis. In these 597 cases, 335 were stage Ib, 71 IIa, 185 IIb, and 6 IIIb. Only 3 (0.5%) of 597 showed ovarian metastasis. All 3 cases were stage IIb. None of stage Ib cancer cases had ovarian metastasis. One (0.19%) of 524 squamous cell carcinomas metastasized to the ovary, whereas 2 (5.5%) of 36 pure adenocarcinomas revealed ovarian metastasis. Interestingly, all ovarian metastatic lesions were microscopic in size and found in the ovarian hilus. As for the primary lesion, all cases with ovarian metastasis showed deep myometrial invasion, corpus invasion, and lymphatic permeation. Two cases showed pelvic lymph node metastases and positive peritoneal washing cytology. From the results of our study, it can be said that it is fairly safe to preserve the ovary at the time of radical operation in squamous cell carcinoma of the uterine cervix, but it may not be safe to preserve the ovary in pure adenocarcinoma of the uterine cervix.

Entities:  

Mesh:

Year:  1991        PMID: 2026359     DOI: 10.1016/0090-8258(91)90253-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Fallopian Tube Mucosal Involvement in Cervical Gastric-type Adenocarcinomas: Report of a Series With Discussion of the Distinction From Synchronous In Situ Tubal Lesions.

Authors:  Simon Rajendran; Yaser Hussein; Kay J Park; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

2.  Secondary Involvement of the Adnexa and Uterine Corpus by Carcinomas of the Uterine Cervix: A Detailed Morphologic Description.

Authors:  Carolina Reyes; Rajmohan Murali; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2015-11       Impact factor: 2.762

3.  Diminished Utilization of in Vitro Fertilization Following Ovarian Transposition in Cervical Cancer Patients.

Authors:  Sana M Salih; Samet Albayrak; Songwon Seo; Sarah L Stewart; Kristen Bradley; David M Kushner
Journal:  J Reprod Med       Date:  2015 Jul-Aug       Impact factor: 0.142

4.  Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

Authors:  Huaiwu Lu; Jing Li; Lijuan Wang; Hui Zhou; Yunyun Liu; Dongyan Wang; Zhongqiu Lin
Journal:  Med Sci Monit       Date:  2016-02-08

5.  Isolated port site recurrence of node-negative clinical stage IB1 cervical adenocarcinoma.

Authors:  Uma Deshmukh; Molly McAdow; Jonathan Black; Pei Hui; Masoud Azodi
Journal:  Gynecol Oncol Rep       Date:  2017-03-06

Review 6.  Port-Site Metastasis in Gynecological Malignancies.

Authors:  Kelly Benabou; Wafa Khadraoui; Tarek Khader; Pei Hui; Rodrigo Fernandez; Masoud Azodi; Gulden Menderes
Journal:  JSLS       Date:  2021 Jan-Mar       Impact factor: 2.172

7.  Bilateral ovarian metastatic squamous cell carcinoma arising from the uterine cervix and eluding the Mullerian mucosa.

Authors:  Sunil Jaiman; Kameswari Surampudi; Sirisha Rao Gundabattula; Deepasha Garg
Journal:  Diagn Pathol       Date:  2014-06-04       Impact factor: 2.644

Review 8.  Stage IA1 HPV-associated cervical squamous cell carcinoma metastasizing to ovary by special pathway: a case report and literature review.

Authors:  Yuanyuan Zhang; Xiaobo Zhang; Huan Wang; Danhua Shen
Journal:  J Ovarian Res       Date:  2022-02-03       Impact factor: 4.234

9.  Ovarian metastasis in women with cervical carcinoma in stages IA to IIB: A systematic review and meta-analysis.

Authors:  Yu Fan; Meng-Yao Wang; Yi Mu; Si-Ping Mo; Ai Zheng; Jin-Ke Li
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.